TY  - GEN
AU  - Thompson,Alastair M
AU  - Johnson,Andrea
AU  - Quinlan,Philip
AU  - Hillman,Grantland
AU  - Fontecha,Marcel
AU  - Bray,Susan E
AU  - Purdie,Colin A
AU  - Jordan,Lee B
AU  - Ferraldeschi,Roberta
AU  - Latif,Ayshe
AU  - Hadfield,Kirsten D
AU  - Clarke,Robert B
AU  - Ashcroft,Linda
AU  - Evans,D Gareth
AU  - Howell,Anthony
AU  - Nikoloff,Michele
AU  - Lawrence,Jeffrey
AU  - Newman,William G
TI  - Comprehensive CYP2D6 genotype and adherence affect outcome in breast cancer patients treated with tamoxifen monotherapy
SN  - 1573-7217
PY  - 2011///0321
KW  - Aged
KW  - Breast Neoplasms
KW  - drug therapy
KW  - Chemotherapy, Adjuvant
KW  - Cytochrome P-450 CYP2D6
KW  - genetics
KW  - Cytochrome P-450 CYP2D6 Inhibitors
KW  - Disease-Free Survival
KW  - Drug Interactions
KW  - Enzyme Inhibitors
KW  - therapeutic use
KW  - Estrogen Receptor Modulators
KW  - metabolism
KW  - Female
KW  - Gene Frequency
KW  - Genotype
KW  - Humans
KW  - Kaplan-Meier Estimate
KW  - Medication Adherence
KW  - Middle Aged
KW  - Phenotype
KW  - Proportional Hazards Models
KW  - Risk Assessment
KW  - Risk Factors
KW  - Tamoxifen
KW  - Time Factors
KW  - Treatment Outcome
N1  - Publication Type: Journal Article; Research Support, Non-U.S. Gov't
UR  - https://doi.org/10.1007/s10549-010-1139-x
ER  -